Kala Study for Persistent Corneal Epithelial Defect
- Trial ID:
- IRB-23-8185
- Peter Krall, MD
Inclusion Criteria
Patients must:- Be 18 or older.
- Have medically documented PCED.
- Be willing to stop current medications.
Exclusion Criteria
Patients must not:- Use any other eye medications other than the study eye drops.
- Have used Oxervate within 30 days.
- Have had any surgical procedures for PCED.
Additional Info
- Participants will be randomized (like the flip of a coin) to the study eye drops or placebo eye drops (no active ingredient).
- An antibiotic eyedrop and artificial tear eyedrop will be provided by the study in addition to the study eyedrop.
- Search NCT 05727878 at https://clinicaltrials.gov website for more information.
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org